Business information provider Thomson Reuters, US, has announced the availability of Cortellis for Informatics, a new capability that speeds access to critical life sciences research and development information found on its premiere life sciences platform, Thomson Reuters Cortellis.
Cortellis for Informatics uses sophisticated application programming interfaces (APIs) to enhance the research and development process by delivering real-time access to powerful information and tools for biopharmaceutical competitive intelligence, drug pipeline, and drug research and development.
Each API integrates Thomson Reuters data with proprietary content and public information sources into a comprehensive view that is customised to meet the needs of a company, team or individual researcher. With Cortellis for Informatics, data can be shared in a number of ways, including dashboards, custom reports and alerts, and intranet and mobile applications.
Cortellis for Informatics streamlines information sharing across all levels of the organisation. Instead of using multiple systems to manage workflows, researchers access up-to-the-minute news in the office, in meetings or at the bench. This ability to deploy Thomson Reuters information across the whole company in real time within internal systems provides greater opportunities for collaboration in the scientific search and discovery process.
Cortellis for Informatics provides web services for investigational drugs, drug targets, ontologies, patents, clinical trials and analytics.
Search for more Reference Tools
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
